A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis (Q34866838)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis |
scientific article |
Statements
1 reference
A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis (English)
1 reference
Sallie B Cosgrove
1 reference
Jody A Wren
1 reference
Dawn M Cleaver
1 reference
Kelly F Walsh
1 reference
Stacey I Follis
1 reference
Vickie I King
1 reference
Jezaniah-Kira S Tena
1 reference
Michael R Stegemann
1 reference
1 December 2013
1 reference
1 reference
24
1 reference
6
1 reference
587-97, e141-2
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference